Quest PharmaTech Inc. (CVE:QPT – Get Free Report)’s share price rose 40% on Friday . The company traded as high as C$0.04 and last traded at C$0.04. Approximately 1,172,033 shares were traded during trading, an increase of 1,485% from the average daily volume of 73,952 shares. The stock had previously closed at C$0.03.
Quest PharmaTech Stock Up 40.0 %
The stock’s 50-day moving average price is C$0.03 and its two-hundred day moving average price is C$0.03. The stock has a market capitalization of C$5.92 million, a P/E ratio of -1.75 and a beta of 0.14. The company has a current ratio of 0.40, a quick ratio of 0.52 and a debt-to-equity ratio of 4.35.
About Quest PharmaTech
Quest PharmaTech Inc, a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer.
Recommended Stories
- Five stocks we like better than Quest PharmaTech
- Upcoming IPO Stock Lockup Period, Explained
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- Do ETFs Pay Dividends? What You Need to Know
- How AI Implementation Could Help MongoDB Roar Back in 2025
- Bank Stocks – Best Bank Stocks to Invest In
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Quest PharmaTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest PharmaTech and related companies with MarketBeat.com's FREE daily email newsletter.
